NSE, the main tumor marker of small cell lung cancer, was significantly higher in group A than the other two groups (P < 0.001), with the highest specificity of NSE in group A (93.3%), indicating that NSE has a high application value in combined detection. The gene discussed is ENO2; the disease is small cell lung carcinoma.